Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
All >

News > Switzerland

Total search results: 2248 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Anergis S.A.. (2/5/14). "Press Release: Anergis Closes Financing Round Totaling CHF 8 M. Preparation of Phase III Trials with Lead Allergy Vaccine AllerT". Epalinges, CH. 2014-02-05
Actelion Ltd.. (1/31/13). "Press Release: Actelion Launches Opsumit in Germany". Allschwil. 2014-01-31
F. Hoffmann-La Roche AG. (1/30/14). "Press Release: Roche Delivers Strong 2013 Results. Group Sales Rise 6% to 46.8 Billion Swiss Francs". Basel. 2014-01-30
Novartis AG. (1/29/14). "Press Release: Novartis Delivers Strong Sales and Innovation in 2013 – Underlying Business Performance Reinforces Growth Prospects". Basel. 2014-01-29
InSphero AG. (1/28/14). "Press Release: InSphero Hires New Director of Global Marketing". Schlieren. 2014-01-28
Prothena Corporation plc. (1/23/14). "Press Release: Prothena to Receive $30 Million Upfront Payment from Roche Triggered by the Expiration of Hart-Scott-Rodino Waiting Period". Dublin. 2014-01-23
Lonza Group Ltd.. (1/23/14). "Press Release: Lonza Delivers Strong Results Following Continuing Success of Transformation Efforts". 2014-01-23
Roche. (1/23/14). "Press Release: Juan Carlos Lopez Appointed Head of Academic Relations & Collaborations at Roche. The Former Chief Editor at Nature Medicine to Spearhead Roche pRED’s Relations with Academic and Non-profit Research Organizations". Basel 2014-01-23
A*STAR. (1/22/14). "Press Release: A*STAR Signs Agreement with Nestlé to Strengthen Food & Nutrition R&D in Singapore". 2014-01-22
Nestlé S.A.. (1/22/14). "Press Release: Nestlé Signs Research Agreement with Singapore". 2014-01-22
Piqur Therapeutics AG. (1/21/14). "Press Release: Piqur Launches Phase I Study with Its Lead Compound PQR309 and Successfully Completes Series A Financing Round". 2014-01-14
Incyte Corporation. (1/13/14). "Press Release: Incyte Names Hervé Hoppenot President and Chief Executive Officer. Former President of Novartis Oncology to Lead Incyte’s Future Growth". Wilmington, DE. 2014-01-13
Solvias AG. (1/13/14). "Press Release: Solvias Appoints New CEO". 2014-01-13
Lonza Group Ltd.. (1/13/14). "Press Release: Lonza Extends Partnership with Pharmacyclics to Support Manfacturing a Recently Approved Oncology Therapeutic, Imbruvica". Basel. 2014-01-13
Agenus Inc.. (1/13/14). "Press Release: Agenus Enters into Definitive Agreement to Acquire Privately Held 4-Antibody AG". Lexington, MA. 2014-01-13
Biognosys AG. (1/10/14). "Press Release: New Financing and Extension of Biognosys’ Management Team". 2014-01-10
Nuevolution A/S. (1/10/14). "Press Release: Nuevolution Announces Technology Licensing Agreement". Copenhagen. 2014-01-10
AC Immune S.A.. (1/9/14). "Press Release: AC Immune Raises CHF 20 Million and Initiates World’s First anti-pTau Vaccine Trial for Alzheimer’s Disease". Lausanne. 2014-01-09
Aravis. (1/9/14). "Press Release: Aravis Strengthens Life Science Team with Three Important Appointments". Zurich. 2014-01-09
Lonza Group Ltd.. (1/9/14). "Press Release: Lonza Signs Exclusive Agreement with Index Ventures for the Development and Manufacture of Biologics for Portfolio Companies". Basel & London. 2014-01-09
Santaris Pharma A/S. (1/9/14). "Press Release: Santaris A/S Announces Worldwide Discovery Alliance for RNA-targeted Medicines with Roche". Hørsholm & San Diego, CA. 2014-01-09
Cellular Dynamics International, Inc.. (1/8/14). "Press Release: Cellular Dynamics Signs Agreement with Nestle Institute of Health Sciences to Supply iCell and MyCell Products for Nutritional Research". Madison, WI. 2014-01-08
Actelion Ltd.. (12/20/13). "Press Release: Actelion Is Granted Marketing Authorisation for Opsumit (macitentan) in Pulmonary Arterial Hypertension (PAH) by the European Commission". Allschwil. 2013-12-20
Prothena Corporation plc. (12/11/13). "Press Release: Roche and Prothena Enter into Worldwide Collaboration to Co-develop and Co-promote Antibodies for Treatment of Parkinson’s Disease". Basel & Dublin. 2013-12-11
Genedata AG. (12/10/13). "Press Release: New Genedata Expressionist for MS Gains Increased Adoption in Metabolomics R&D". Basel. 2013-12-10
Covagen AG. (12/9/13). "Press Release: Covagen Secures CHF 42 Million in Series B Financing". Zürich-Schlieren. 2013-12-09
Biocartis S.A.. (12/6/13). "Press Release: Biocartis and VIB Join Forces to Develop Unique Diagnostic Cancer Test". Mechelen & Lausanne. 2013-12-06
Novartis AG. (12/6/13). "Press Release: Novartis Investigational Compound LBH589 Significantly Extended Time without Disease Progression in Phase III Multiple Myeloma Study". Basel. 2013-12-06
Evolva Holding S.A.. (12/5/13). "Press Release: Evolva to Participate in European Research Project". Reinach. 2013-12-05
Roche. (12/4/13). "Press Release: Roche and Molecular Partners Enter into Alliance to Develop New Cancer Treatments. Partnership Will Combine Novel Biologics (DARPins) with Roche Drug-conjugate Technology". Basel & Zürich-Schlieren. 2013-12-04
Redbiotec AG. (12/3/13). "Press Release: Collaboration with GSK Vaccines". Schlieren. 2013-12-03
Genedata AG. (12/3/13). "Press Release: Genedata Announces Collaboration with AstaZeneca on the Analysis of Compound Combination Experiments". Basel. 2013-12-03
Actelion Ltd.. (12/2/13). "Press Release: Update on the DUAL Program in Digital Ulcers in Systemic Sclerosis". Allschwil. 2013-12-02
Telormedix S.A.. (12/2/13). "Press Release: Telormedix Raises CHF 6 M ($6.6 M) in Series B Financing Round". Bioggio, TI. 2013-12-02
Biocartis S.A.. (11/28/13). "Press Release: Biocartis Announces the End of Its Alliance with bioMérieux". Mechelen & Lausanne. 2013-11-28
bioMérieux S.A.. (11/28/13). "Press Release: bioMérieux Announces Termination of Its Collaboration with Biocartis in Molecular Biology". Marcy l’Étoile. 2013-11-28
InSphero AG. (11/25/13). "Press Release: InSphero’s New EU Subsidiary Opens for Business". Schlieren. 2013-11-25
Covagen AG. (11/21/13). "Press Release: Covagen and Tanabe Research Laboratories Expand Strategic Research Collaboration for Development of Bispecific FynomAbs". Zürich-Schlieren. 2013-11-21
Eloxx Pharmaceuticals, Ltd.. (11/21/13). "Press Release: Eloxx Pharmaceuticals, Ltd. Announced the Initial Closing of its First Round of Financing". Herzliya. 2013-11-21
Selexis S.A.. (11/19/13). "Press Release: Selexis SA Names Dr. Marco Bocci Director of European Sales and Business Development". Geneva. 2013-11-19
Cytos Biotechnology AG. (11/18/13). "Press Release: Rights Offering Oversubscribed – CHF 24.3 Million Raised". Schlieren. 2013-11-18
Basilea Pharmaceutica Ltd.. (11/18/13). "Press Release: Basilea Reports Isavuconazole Orphan Drug Designation for Treatment of Zygomycosis by U.S. FDA". Basel. 2013-11-18
InSphero AG. (11/18/13). "Press Release: Cambridge Bioscience Our New Distributor for the UK". 2013-11-18
Immunocore Ltd.. (11/14/13). "Press Release: Immunocore Appoints Dr Jonathan Knowles as Chairman of the Board". Oxford. 2013-11-14
Immatics Biotechnologies GmbH. (11/13/13). "Press Release: Immatics and Roche Sign Cancer Vaccine and Immunotherapy Collaboration". Tübingen & Basel. 2013-11-13
Novartis AG. (11/11/13). "Press Release: Novartis Announces Divestiture of Its Blood Transfusion Diagnostics Unit to Grifols. Spain-based Grifols to Acquire Novartis Blood Transfusion Diagnostics Unit for USD 1.675 Billion". Basel. 2013-11-11
Biocartis S.A.. (11/5/13). "Press Release: Biocartis Poised for 2014 Commercial Launch with EUR 30 Million Series E Equity Fundraising". Mechelen & Lausanne. 2013-11-05
ADC Therapeutics S.a.r.l.. (11/5/13). "Press Release: ADC Therapeutics Licenses Proprietary Antibodies from Five Prime Therapeutics, Adds an Additional Proprietary ADC Development Program in Oncology". Lausanne & South San Francisco, CA. 2013-11-05
CureVac GmbH. (11/4/13). "Press Release: CureVac Collaborates with the Cancer Research Institute and Ludwig Cancer Research to Enalbe Clinical Testing of Novel Immunotherapy Treatment Options for Cancer". Tübingen & New York, NY. 2013-11-04
Roche. (11/4/13). "Press Release: Roche and Polyphor Join Efforts to Combat Multi-drug-resistant Bacterial Infections". Basel. 2013-11-04
Biognosys AG. (11/1/13). "Press Release: New Release of iRT Kit". 2013-11-01
Anton Paar GmbH. (11/13). "Press Release: Anton Paar GmbH Acquires CSM Instruments SA". 2013-11-01
Genedata AG. (10/30/13). "Press Release: Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support". Basel. 2013-10-30
ETH Zürich. (10/29/13). "Press Release: An Artificial Enzyme that Promotes 700 Reactions per Second". 2013-10-29
Tecan Group Ltd.. (10/29/13). "Press Release: Tecan’s AC Extraction Plate Provides a Unique Sample Preparation Tool for LC-MS". Männedorf. 2013-10-29
Biognosys AG. (10/25/13). "Press Release: SWATH Enabling Software Spectronaut Referenced in Recent Publications". 2013-10-25
Basilea Pharmaceutica Ltd.. (10/23/13). "Press Release: Basilea’s Antibiotic Ceftobiprole Obtains Regulatory Approval in Europe for Pneumonia". Basel. 2013-10-23
Biocartis S.A.. (10/22/13). "Press Release: Biocartis Presents the Successful Use of Idylla for the Detection of BRAF Mutation Status in Tumour Samples at the International AACR Congress in Boston". Mechelen & Lausanne. 2013-10-22
Finox AG (Finox Biotech). (10/22/13). "Press Release: Finox Biotech Shareholders Agree Capital Increase". Burgdorf. 2013-10-22
Novartis AG. (10/22/13). "Press Release: Novartis Delivers Strong Sales Performance in Third Quarter Driven by Growth Products’ Momentum – Innovation Newsflow Reinforces Growth Prospects". Basel. 2013-10-22
Samsung BioLogics. (10/22/13). "Press Release: Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche". Seoul. 2013-10-22
Tecan Group Ltd.. (10/22/13). "Press Release: Enhancing Clinical Diagnostics with Tecan’s Cavro OmniRobot". Männedorf. 2013-10-22
Biognosys AG. (10/18/13). "Press Release: US Patent Awarded to Biognosys". 2013-10-18
Actelion Ltd.. (10/18/13). "Press Release: Actelion Receives US FDA Approval for Opsumit (macitentan) for the Treatment of Pulmonary Arterial Hypertension". Allschwil. 2013-10-18
Actelion Ltd.. (10/17/13). "Press Release: Actelion on Track to Deliver Double Digit LC Core Earnings Growth". Allschwil. 2013-10-17
Biocartis S.A.. (10/17/13). "Press Release: Biocartis and Hospital del Mar Join Forces to Develop Diagnostic Colon Cancer Test". Lausanne, Mechelen & Barcelona. 2013-10-17
Biodesy, Inc.. (10/17/13). "Press Release: Biodesy Inc. Completes $15.0 Million Series A Financing and Appoints Greg Yap as Chief Executive Officer. Series A Investors include 5AM Ventures, Pfizer Venture Investments and Roche Venture". Burlingame, CA. 2013-10-17
Roche. (10/17/13). "Press Release: Roche Posts Strong Sales Growth in the First Nine Months of 2013". Basel. 2013-10-17
Roche. (10/14/13). "Press Release: Roche to Invest 800 Million Swiss Francs in Global Biologic Medicine Manufacturing Network". Basel. 2013-10-14
ImmunoGen, Inc.. (10/11/13). "Press Release: ImmunoGen, Inc. Announces New License Agreement". Waltham, MA. 2013-10-11
Cytos Biotechnology AG. (10/10/13). "Press Release: Cytos Biotechnology Plans Financing of up to CHF 17.6 Million. CHF 9 Million of Proposed Capital Increase Already Firmly Committed by Existing Investors". Schlieren. 2013-10-10
Curetis AG. (10/9/13). "Press Release: Curetis Presents New Clinical Validation Data on Its Unyvero P50 Pneumonia / LRT Application". Holzgerlingen. 2013-10-09
Tecan Group Ltd.. (10/9/13). "Press Release: Tecan Maintains Target for Profitability and Adjusts Revenue Guidance for 2013". Männedorf. 2013-10-09
Debiopharm S.A.. (10/7/13). "Press Release: Experimental Therapeutics Centre and Debiopharm Group to Collaborate for the Development of an Epigenetic Innovative Oncology Target". Singapore & Lausanne. 2013-10-07
Acino Holding AG. (10/2/13). "Press Release: Avista Capital Partners and Nordic Capital to Launch a Joint Public Tencer Offer to Acquire Acino. Offer Price of CHF 115.00 Represents a 33% Premium to the Closing Share Price on October 1, 2013". Aesch. 2013-10-02
MorphoSys AG. (10/2/13). "Press Release: MorphoSys Collaborator to Start Pivotal Study with Bimagrumab. MorphoSys to Receive Clinical Milestone Payment". 2013-10-02
EffRx Pharmaceuticals S.A.. (10/1/13). "Press Release: EffRx Receives Prestigious EUR 5.9 Million FP7 Research Grant for the Development of EX404 for PolyCystic Ovary Syndrome (PCOS) in Paediatric Populations". Freienbach. 2013-10-01
Dualsystems Biotech AG. (9/30/13). "Press Release: Dualsystems Biotech Closes Series C Financing Round". 2013-09-30
Basilea Pharmaceutica Ltd.. (9/30/13). "Press Release: Basilea Reports Positive Topline Phase 3 Results for Antifungal Isavuconazole". Basel. 2013-09-30
Biognosys AG. (9/27/13). "Press Release: New MRM Panel for Dried Blood Spot Samples". 2013-09-27
M+W Group. (9/27/13). "Press Release: M+W Group Hands Over Most Advanced Research Laboratory to Nestlé". 2013-09-27
Actelion Ltd.. (9/19/13). "Press Release: Actelion Closes Acquisition of Privately-held Ceptaris Therapeutics Adding Valchlor to Actelion’s Product Portfolio. Valchlor Is the Only FDA-approved Topical Formulation of Mechlorethamine". Allschwil. 2013-09-19
BioGenes GmbH. (9/18/13). "Press Release: BioGenes Launches Enhanced Generic HCP Assay for Early Stage Biologics Production". Berlin. 2013-09-18
Addex Therapeutics S.A.. (9/17/13). "Press Release: Addex Therapeutics First Half 2013 Financial Results". Geneva. 2013-09-17
Genedata AG. (9/17/13). "Press Release: Evonik and Genedata Broaden Their Collaboration with the Genedata Selector Biotechnology Data Management Platform". Basel. 2013-09-17
Roche. (9/16/13). "Press Release: Christoph Franz Nominated to Become New Roche Chairman". Basel. 2013-09-16
Inovio Pharmaceuticals, Inc.. (9/10/13). "Press Release: Roche and Inovio Pharmaceuticals Partner On Inovio’s Prostate and Hepatitis B Immunotherapy Products". Basel & Blue Bell, PA. 2013-09-10
Debiopharm S.A.. (9/9/13). "Press Release: Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm". Lausanne & Kolkata. 2013-09-09
Evolva Holding S.A.. (9/9/13). "Press Release: Cargill and Evolva Move into Pilot Scale ahead of Schedule for Fermentation-based Steviol Glycosides". Minneapolis, MN & Reinach. 2013-09-09
Genkyotex S.A.. (9/9/13). "Press Release: Genkyotex Receives FDA IND Approval for Phase II Clinical Study with First in Class NOX Inhibitor GTK137831". Geneva & Archamps. 2013-09-09
Bruker Corporation. (9/9/13). "Press Release: Bruker Introduces New Benchtop FT-NMR System Fourier 60". Indianapolis, IN. 2013-09-09
Novartis AG. (9/6/13). "Press Release: Novartis Announces an Exclusive Global Licensing and Research Collaboration with Regenerex, Leveraging a Novel Cell Platform to Broaden Presence in the Cell Therapy Space". Basel. 2013-09-06
Debiopharm S.A.. (9/5/13). "Press Release: Go To Market Consulting Inc. and Debiopharm Group Collaborate to Identify Early Stage In-licensing Opportunities on the US West Coast". Lausanne & San Francisco, CA. 2013-09-05
Piqur Therapeutics AG. (9/5/13). "Press Release: Piqur Successfully Closed a Third Seed Financing Round and Received Eurostars Grant". Basel. 2013-09-05
Analytik Jena AG. (9/4/13). "Press Release: Analytik Jena AG Approves a Subscription Rights Capital Increase of up to 1.95 Million New Shares (Ad-hoc notification in accordance with Section 15 WpHG [Securities Trading Act])". Jena. 2013-09-04
Genedata AG. (9/4/13). "Press Release: Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening". Basel. 2013-09-04
Roche. (9/4/13). "Press Release: Start of the TROPICAL-ACS Large Intervention Study on Multiplate-guided Anti-platelet Therapy in ACS Patients". Rotkreuz. 2013-09-04
Santhera Pharmaceuticals. (9/3/13). "Press Release: Santhera Closes License-back Deal with Takeda for European Rights to Catena in Duchenne Muscular Dystrophy". Liestal. 2013-09-03
Zealand Pharma A/S. (9/3/13). "Press Release: Zealand Appoints New Chief Scientific Officer. Dr Torsten Hoffmann Joins from Roche". Copenhagen. 2013-09-03
Genedata AG. (9/3/13). "Press Release: Genedata Screener Extends Support for High-throughput Thermofluor Assays". Basel. 2013-09-03
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page



Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75

» top